Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cogent Solutions Group LLC
WARNING LETTER
•Cogent Solutions Group LLC•November 10, 2009

Cogent Solutions Group LLC – FDA Warning Letter, Nov 10, 2009

Record Details

This FDA Warning Letter, issued to Cogent Solutions Group, L.L.C. on May 12, 2010, follows a November 2009 inspection and review of product labels and websites for "Runovia," "Trixsyn," and "Hyaluronex." The FDA determined that all three products are unapproved new drugs due to therapeutic claims for disease diagnosis, cure, mitigation, treatment, or prevention in humans or animals, violating section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act. Specifically, "Runovia" is an unapproved new drug under section 201(p) and 505(a) for human use. "Trixsyn" and "Hyaluronex" are unapproved new animal drugs under sections 201(v) and 512(a), making them unsafe and adulterated under section 501(a)(5), and their interstate commerce unlawful under section 301(a). Additionally, "Runovia" is a misbranded dietary supplement under sections 403(i)(1), 403(s)(2)(B), and 403(q)(5)(F) of the Act, and 21 CFR 101.3(a), (g), 101.36, and 101.4(g). Misbranding issues include failure to identify as a "dietary supplement," non-compliant nutrition information formatting (type size, title, subheading placement), and incorrect placement of the "Other ingredients" list. The firm is required to promptly correct these violations, investigate their causes, and prevent recurrence. Failure to comply within fifteen working days may result in enforcement actions like seizure or injunction, and impact federal contracts.

Company
Cogent Solutions Group LLC
Inspection date
November 10, 2009
Product type
Drugs
Office
Cincinnati District Office
People
  • Teresa C. Thompson
  • Douglas W. Kiburz
  • William Thorn
  • Mark M. Reed
View Company Profile

ID · 183bf3bd-28a9-428a-bf1a-350c8a985519

Violation Codes10
21 U.S.C. 343(q)(5)(F)21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 321(v)21 U.S.C. 360b(a)21 U.S.C. 360b(b)21 U.S.C. 360ccc21 U.S.C. 360ccc-1

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cogent Solutions Group LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.